Ana J. Manovel-Sanchez

Clinical utility of neurofilament light chain as a biomarker for disease onset and progression in hereditary transthyretin amyloidosis.

Journal: Frontiers in neurology

Published: July 05, 2025

Predictors of poor prognosis in a large cohort of patients with hereditary cardiac transthyretin amyloidosis.

Journal: Revista espanola de cardiologia (English ed.)

Published: June 03, 2025

Atrial septal pouch as the main cause of failed transseptal puncture in pulmonary vein isolation.

Journal: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing

Published: February 27, 2025

Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv).

Journal: Scientific reports

Published: November 06, 2023

His bundle pacing success and electrical parameter stability regardless of three-dimensional transthoracic echocardiography lead localization.

Journal: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing

Published: November 28, 2022

Ischemia-guided vs routine non-culprit vessel angioplasty for patients with ST segment elevation myocardial infarction and multi-vessel disease: the IAEA SPECT STEMI trial.

Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Published: July 06, 2022

Characterization of hereditary transthyretin cardiac amyloidosis in Spain.

Journal: Revista espanola de cardiologia (English ed.)

Published: March 24, 2021

Early improvement of left ventricular ejection fraction by cardiac resynchronization through His bundle pacing in patients with heart failure.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: March 27, 2019

Clinical utility of neurofilament light chain as a biomarker for disease onset and progression in hereditary transthyretin amyloidosis.

Clinical utility of neurofilament light chain as a biomarker for disease onset and progression in hereditary transthyretin amyloidosis.

Predictors of poor prognosis in a large cohort of patients with hereditary cardiac transthyretin amyloidosis.

Predictors of poor prognosis in a large cohort of patients with hereditary cardiac transthyretin amyloidosis.

Atrial septal pouch as the main cause of failed transseptal puncture in pulmonary vein isolation.

Atrial septal pouch as the main cause of failed transseptal puncture in pulmonary vein isolation.

Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv).

Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv).

His bundle pacing success and electrical parameter stability regardless of three-dimensional transthoracic echocardiography lead localization.

His bundle pacing success and electrical parameter stability regardless of three-dimensional transthoracic echocardiography lead localization.

Ischemia-guided vs routine non-culprit vessel angioplasty for patients with ST segment elevation myocardial infarction and multi-vessel disease: the IAEA SPECT STEMI trial.

Ischemia-guided vs routine non-culprit vessel angioplasty for patients with ST segment elevation myocardial infarction and multi-vessel disease: the IAEA SPECT STEMI trial.

Characterization of hereditary transthyretin cardiac amyloidosis in Spain.

Characterization of hereditary transthyretin cardiac amyloidosis in Spain.

Early improvement of left ventricular ejection fraction by cardiac resynchronization through His bundle pacing in patients with heart failure.

Early improvement of left ventricular ejection fraction by cardiac resynchronization through His bundle pacing in patients with heart failure.

Coronary-myocardial-valvular Percutaneous Intervention.

Coronary-myocardial-valvular Percutaneous Intervention.

Ventricular resynchronization therapy by direct His-bundle pacing using an internal cardioverter defibrillator.

Ventricular resynchronization therapy by direct His-bundle pacing using an internal cardioverter defibrillator.

Electrical and mechanical cardiac resynchronisation by novel direct his-bundle pacing in a heart failure patient.

Electrical and mechanical cardiac resynchronisation by novel direct his-bundle pacing in a heart failure patient.

Uncommon insertion of papillary muscles and abnormal cardiac rotation.

Uncommon insertion of papillary muscles and abnormal cardiac rotation.